Post-natal cardiomyocytes can generate iPS cells with an enhanced capacity toward cardiomyogenic re-differentation.
about
Inhibition of H3K9 methyltransferases G9a/GLP prevents ototoxicity and ongoing hair cell death.PlGF-MMP9-engineered iPS cells supported on a PEG-fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardiumEnhanced generation of human induced pluripotent stem cells by ectopic expression of Connexin 45.Genetically matched human iPS cells reveal that propensity for cartilage and bone differentiation differs with clones, not cell type of originThe RNA binding protein ESRP1 fine-tunes the expression of pluripotency-related factors in mouse embryonic stem cellsMicroRNAs contribute to induced pluripotent stem cell somatic donor memory.Reprogramming-derived gene cocktail increases cardiomyocyte proliferation for heart regeneration.Stem Cell Differentiation Stage Factors from Zebrafish Embryo: A Novel Strategy to Modulate the Fate of Normal and Pathological Human (Stem) CellsDisease modelling using induced pluripotent stem cells: status and prospects.Endogenous cardiac stem cells for the treatment of heart failure.Cellular therapies based on stem cells and their insulin-producing surrogates: a 2015 reality check.Preferential Lineage-Specific Differentiation of Osteoblast-Derived Induced Pluripotent Stem Cells into Osteoprogenitors.Establishment of human cell type-specific iPS cells with enhanced chondrogenic potential.Skeletal Muscle Cell Induction from Pluripotent Stem Cells.Generation of new cardiomyocytes after injury: de novo formation from resident progenitors vs. replication of pre-existing cardiomyocytes.Molecular Imaging for Comparison of Different Growth Factors on Bone Marrow-Derived Mesenchymal Stromal Cells' Survival and Proliferation In Vivo.Selection via pluripotency-related transcriptional screen minimizes the influence of somatic origin on iPSC differentiation propensity.Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells.Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation.A multi-cellular 3D bioprinting approach for vascularized heart tissue engineering based on HUVECs and iPSC-derived cardiomyocytes
P2860
Q30542318-293FD3BC-98E5-44E8-B7D9-65A2726001E1Q30573513-6A769547-8EE1-4832-86B5-C471DB5785C4Q33672340-AB473708-14C3-419B-81F3-392DD6E703A7Q34575252-7B038FFB-038D-41CC-A5FF-1D1FEC7451BAQ34981447-C8158C8B-AD77-48DF-B8F4-7221AB63DD31Q37511708-CCD9E9C3-2AFE-4246-B1D0-7D329BF78948Q37617991-27D36D9F-5E07-4E0F-8BA2-A2657009640EQ37741546-42203DA8-2A3C-44F8-B47C-7EAD7A1C4AF4Q38059468-61EFA931-C529-4D4A-BF97-BAC57EEB485CQ38178645-33995D96-87CB-417F-AE7B-238A7C7CDC4BQ38344424-99E2FFF1-2963-41E9-A976-FF6710B94AE3Q38751740-D81E33B2-82FD-435E-8E88-C7DB361DE4A7Q38981862-62EB6D58-E627-44E5-BDF9-6EEC640FD5B9Q39321274-E8B03B2F-8231-4F3F-B0BB-1685F015B1F5Q40859404-E5A080EA-3239-4CAB-AD55-2FFDF6FCE277Q41827722-B3D03BAA-8790-433C-9159-98990AA53672Q42146807-4C291F44-3822-4B66-A875-52EC24F0CA09Q42521874-2FC4BDA5-8EDD-4EE0-91FA-E40E3D506190Q48162963-DCDBCDD6-11C4-4ABF-B583-D1C5794C4096Q58756008-22FA4CBD-D337-4134-B66F-2F21113B7175
P2860
Post-natal cardiomyocytes can generate iPS cells with an enhanced capacity toward cardiomyogenic re-differentation.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Post-natal cardiomyocytes can ...... diomyogenic re-differentation.
@ast
Post-natal cardiomyocytes can ...... diomyogenic re-differentation.
@en
type
label
Post-natal cardiomyocytes can ...... diomyogenic re-differentation.
@ast
Post-natal cardiomyocytes can ...... diomyogenic re-differentation.
@en
prefLabel
Post-natal cardiomyocytes can ...... diomyogenic re-differentation.
@ast
Post-natal cardiomyocytes can ...... diomyogenic re-differentation.
@en
P2093
P2860
P356
P1476
Post-natal cardiomyocytes can ...... diomyogenic re-differentation.
@en
P2093
C Altomare
E Di Pasquale
G Condorelli
M V G Latronico
P Cattaneo
P Portararo
P2860
P2888
P304
P356
10.1038/CDD.2011.205
P577
2012-01-20T00:00:00Z
P5875
P6179
1008180118